Research ArticleClinical Studies
Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene
ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, MARTIN SVATON, MAREK MINARIK, LUCIE BENESOVA, ZBYNEK BORTLICEK, RADEK KUCERA and ONDREJ TOPOLCAN
Anticancer Research January 2016, 36 (1) 447-453;